About This 510(k) Submission
K250275 is an FDA 510(k) clearance for the PrecisePath? Radiofrequency Puncture Generator and PrecisePath? Footswitch, a Electrosurgical, Cutting & Coagulation & Accessories (Class II — Special Controls, product code GEI), submitted by Baylis Medical Technologies, Inc. (Mississauga, CA). The FDA issued a Cleared decision on October 28, 2025, 270 days after receiving the submission on January 31, 2025. This device falls under the General & Plastic Surgery review panel. Regulated under 21 CFR 878.4400.